Ambrx Biopharma, Inc.

Delisted

CIK 1990550fmd_0J25K94AW33K4DPJ4P3HEQ4BP5Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2022 to Sep 30, 2023, 2 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.